What Does 'Atypia' or 'Atypical Cells' Mean?

This page is for anyone whose biopsy or cell test report uses the word "atypia." It explains what the word means, why it happens, and what usually comes next.

Atypia means the cells look somewhat abnormal under the microscope. They do not look abnormal enough to call them cancer. It sits between "normal" and "cancer." Pathologists use this word when cells raise a question, but do not answer it.

You might see this word after imaging led to a biopsy, or after cells were collected with a fine needle. The exact wording depends on where the sample came from.

Cells can look unusual for many reasons. Most have nothing to do with cancer. Inflammation can distort how cells appear. So can infection, recent injury, or healing. Hormone changes can also change how cells look. Early, truly precancerous change is on this list too. But it is only one possible cause among several.

The causes range from harmless to worth watching. That is why atypia almost always leads to a closer look, not immediate treatment.

Different tissues use different systems for grading this kind of uncertainty. For thyroid nodules checked with a needle, the Bethesda System has a specific category. It is called "atypia of undetermined significance." Ask your team what the chance of cancer is for your result and what they plan to do next, such as repeating the needle test or other steps.

In the breast, atypia often shows up as atypical ductal hyperplasia or atypical lobular hyperplasia. These describe cells that are growing in greater numbers. The cells also look somewhat unusual. Both findings are linked with higher lifetime breast cancer risk. The American Cancer Society says the risk of breast cancer is about 4 to 5 times higher than for a woman with no breast hyperplasia. That higher risk applies to the breast in general. It does not mean cancer is growing at that exact spot. The American Cancer Society says surgery to remove more tissue around it may be recommended. This is more often advised for atypical ductal hyperplasia than for atypical lobular hyperplasia, where close follow-up imaging is another option.

The next step depends on where the atypia was found. It also depends on which system reported it. Some situations call for a repeat sample after a period of time. This checks whether the finding has resolved. Others call for removing more tissue. This can happen because the risk is higher, or because a small sample cannot rule out something worse nearby. Still others call for closer monitoring over time, with no procedure right away.

Sometimes the cause was temporary, like inflammation or a healing injury. In that case, a repeat test often shows the cells have returned to normal.

Atypia is not a cancer diagnosis on its own. Seeing this word on a report is unsettling. But it is a prompt for follow-up, not a verdict.

Atypia is not usually an emergency, but it needs follow-up. Ask your team how soon the next step should happen. If your team recommends removing more tissue, ask when.

• Where exactly was the atypia found, and which grading system was used?
• What is the estimated chance this represents something more serious?
• Is the plan to repeat testing, remove more tissue, or monitor over time?
• Does this finding change my future screening schedule?

Cells can look unusual for reasons that have nothing to do with disease, and the line between "atypical" and something more definite is not always sharp. If your report uses this word and you feel uncertain about next steps, asking about a second review is a reasonable, common request.

Waiting for a repeat test or more tissue sampling after an atypia result is stressful, even though the finding itself is not a cancer diagnosis. It can help to ask your team for a specific date, rather than an open-ended "in a few weeks," so you have a concrete point to plan around. If your worry while waiting feels hard to manage, ask whether your cancer center has patient navigators or counselors. Ask whether this help is available while your result is still uncertain.

• National Cancer Institute — NCI Dictionary of Cancer Terms
• American Cancer Society — Hyperplasia of the Breast (Ductal or Lobular)